Abstract
Vitamin-D-receptor (VDR) mediates immunomodulatory effects of vitamin-VD3 (VD3). The VDRrs1544410_ GG polymorphism has been associated with delayed progression rates to AIDS and resistance to HIV-1 infection. The aim of the present study was to investigate differences in VD3 mediated effects on rs1544410 genotyped dendritic cells (DCs) and macrophages (MDM), key cells involved in HIV-1 infection. Immature DCs exhibited lower bactin- normalized VDR mRNA expression in rs1544410_GG compared to cells with a rs1544410_AA genotype. VD3 response on cell differentiation markers (CD14 inhibition and CD209 induction) was two-fold higher in rs1544410_AA (CD209, p=0.012; CD14, p=0.02). HIV-1-LTR reporter gene activity in MDM was boosted by VD3 ; however, the effect was up to 50% higher in rs1544410_AA. We conclude that the rs1544410_AA association with progression to AIDS and resistance to HIV-1 appears to be linked to an enhanced response to VD3.
Keywords: Vitamin-D-receptor, rs1544410, dendritic cells, HIV-1, CD209, CD14, LTR
Current HIV Research
Title: Immunophenotype of Vitamin D Receptor Polymorphism Associated to Risk of HIV-1 Infection and Rate of Disease Progression
Volume: 8 Issue: 6
Author(s): Carmen Torres, Manuel Sanchez-de-la-Torre, Carelia Garcia-Moruja, Antonio Jose Carrero, Maria del Monte Trujillo, Joan Fibla and Antonio Caruz
Affiliation:
Keywords: Vitamin-D-receptor, rs1544410, dendritic cells, HIV-1, CD209, CD14, LTR
Abstract: Vitamin-D-receptor (VDR) mediates immunomodulatory effects of vitamin-VD3 (VD3). The VDRrs1544410_ GG polymorphism has been associated with delayed progression rates to AIDS and resistance to HIV-1 infection. The aim of the present study was to investigate differences in VD3 mediated effects on rs1544410 genotyped dendritic cells (DCs) and macrophages (MDM), key cells involved in HIV-1 infection. Immature DCs exhibited lower bactin- normalized VDR mRNA expression in rs1544410_GG compared to cells with a rs1544410_AA genotype. VD3 response on cell differentiation markers (CD14 inhibition and CD209 induction) was two-fold higher in rs1544410_AA (CD209, p=0.012; CD14, p=0.02). HIV-1-LTR reporter gene activity in MDM was boosted by VD3 ; however, the effect was up to 50% higher in rs1544410_AA. We conclude that the rs1544410_AA association with progression to AIDS and resistance to HIV-1 appears to be linked to an enhanced response to VD3.
Export Options
About this article
Cite this article as:
Torres Carmen, Sanchez-de-la-Torre Manuel, Garcia-Moruja Carelia, Carrero Jose Antonio, Trujillo del Monte Maria, Fibla Joan and Caruz Antonio, Immunophenotype of Vitamin D Receptor Polymorphism Associated to Risk of HIV-1 Infection and Rate of Disease Progression, Current HIV Research 2010; 8 (6) . https://dx.doi.org/10.2174/157016210793499330
DOI https://dx.doi.org/10.2174/157016210793499330 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Hypersensitivity: Epidemiology and Risk Factors
Current Pharmaceutical Design α(N)-Heterocyclic Thiosemicarbazones: Iron Chelators that are Promising for Revival of Gallium in Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?
Current Vascular Pharmacology Ion Channel Architecture of the Renal Microcirculation
Current Hypertension Reviews Endothelial (Dys)Function in Lone Atrial Fibrillation
Current Pharmaceutical Design Potential Role of TRP Channels in Cough Hypersensitivity?
Current Respiratory Medicine Reviews Current In Vitro Kinase Assay Technologies: The Quest for a Universal Format
Current Drug Discovery Technologies Atranorin – An Interesting Lichen Secondary Metabolite
Mini-Reviews in Medicinal Chemistry Gene Therapy with Transcription Factor Decoy Oligonucleotides as a Potential Treatment for Cardiovascular Diseases
Current Drug Targets Future Treatment for COPD: Targeting Oxidative Stress and its Related Signal
Recent Patents on Inflammation & Allergy Drug Discovery A Plant-Defensin from Sugarcane (Saccharum spp.)
Protein & Peptide Letters Non-Nucleoside Inhibitors of NS5B Polymerase Binding to Allosteric Sites: 3DQSAR and Molecular Docking Studies
Current Medicinal Chemistry Neuroprotective Effects of an Erythropoietin-Derived Peptide in PC1 2 Cells under Oxidative Stress
CNS & Neurological Disorders - Drug Targets Melanocortin Receptor Type 3 as a Potential Target for Anti-Inflammatory Therapy
Current Drug Targets - Inflammation & Allergy The Professional Phagocyte Dictyostelium discoideum as a Model Host for Bacterial Pathogens
Current Drug Targets Inhibitory Mechanisms of CME-1, a Novel Polysaccharide from the Mycelia of Cordyceps sinensis, in Platelet Activation
Current Pharmaceutical Biotechnology Innate T-Cell Immunity in HIV Infections: The Role of Vg9Vd2 T Lymphocytes
Current Molecular Medicine Imidazoles as Promising Scaffolds for Antibacterial Activity: A Review
Mini-Reviews in Medicinal Chemistry CoMFA and CoMSIA Studies on Aryl Carboxylic Acid Amide Derivatives as Dihydroorotate Dehydrogenase (DHODH) Inhibitors
Current Computer-Aided Drug Design Synergy Against Fungal Pathogens: Working Together is Better Than Working Alone
Current Medicinal Chemistry